General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3
- PMID: 36356248
- DOI: 10.1097/AOG.0000000000004899
General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3
Abstract
The purpose of this document is to review currently available management options, general principles, and counseling approaches for reproductive-aged patients requesting menstrual suppression. It includes considerations for unique populations, including adolescents, patients with physical or cognitive disabilities or both, and those with limited access to health care. Gynecologists should be familiar with the use of hormonal therapy for menstrual suppression (including combined oral contraceptive pills, combined hormonal patches, vaginal rings, progestin-only pills, depot medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine device, and the etonogestrel implant). Approaches to counseling should be individualized based on patient preferences and goals, average treatment effectiveness, and contraindications or risk factors for adverse events. Counseling regarding the choice of hormonal medication for menstrual suppression should be approached with the utmost respect for patient autonomy and be free of coercion. Complete amenorrhea may be difficult to achieve; thus, obstetrician-gynecologists and other clinicians should counsel patients and caregivers, if applicable, about realistic expectations.
Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Comment in
-
ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression.Obstet Gynecol. 2022 Dec 1;140(6):1079-1080. doi: 10.1097/AOG.0000000000005007. Obstet Gynecol. 2022. PMID: 36441935 No abstract available.
Similar articles
-
Menstrual Suppression.2024 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 37276279 Free Books & Documents.
-
Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions: A Population Study in an Australian Quaternary Pediatric and Adolescent Gynecology Service from January 2005 to December 2015.J Pediatr Adolesc Gynecol. 2019 Oct;32(5):535-540. doi: 10.1016/j.jpag.2019.05.005. Epub 2019 Jun 8. J Pediatr Adolesc Gynecol. 2019. PMID: 31181330
-
Satisfaction With Hormonal Treatment for Menstrual Suppression in Adolescents and Young Women With Disabilities.J Adolesc Health. 2021 Sep;69(3):482-488. doi: 10.1016/j.jadohealth.2021.01.031. Epub 2021 Mar 10. J Adolesc Health. 2021. PMID: 33712384
-
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2. Contraception. 1995. PMID: 8585882 Review.
-
Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.Hum Reprod Update. 2015 Sep-Oct;21(5):640-51. doi: 10.1093/humupd/dmv023. Epub 2015 Jun 1. Hum Reprod Update. 2015. PMID: 26037216 Review.
Cited by
-
Quantifying menorrhagia and overview of nonsurgical management of heavy menstrual bleeding.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):367-375. doi: 10.1182/hematology.2024000661. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39643997 Free PMC article. Review.
-
Simulation Bridges LGBTQ+ Educational Gaps in Gynecologic Care: Menstrual Suppression for a Gender and Sexually Diverse Patient.MedEdPORTAL. 2025 Apr 1;21:11511. doi: 10.15766/mep_2374-8265.11511. eCollection 2025. MedEdPORTAL. 2025. PMID: 40171214 Free PMC article.
-
"They had the lunch lady coming up to assist": The experiences of menarche and menstrual management for adolescents with physical disabilities.Disabil Health J. 2023 Oct;16(4):101510. doi: 10.1016/j.dhjo.2023.101510. Epub 2023 Jul 20. Disabil Health J. 2023. PMID: 37544804 Free PMC article.
-
Characterization of iron status biomarkers and hematological indices among young adults of East Asian or Northern European ancestry: A cross-sectional analysis from the Iron Genes in East Asian and Northern European Adults Study (FeGenes).Am J Clin Nutr. 2025 Feb;121(2):394-405. doi: 10.1016/j.ajcnut.2024.10.014. Am J Clin Nutr. 2025. PMID: 39909709
-
Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions.Hum Reprod. 2024 Jan 5;39(1):18-34. doi: 10.1093/humrep/dead206. Hum Reprod. 2024. PMID: 37951241 Free PMC article.
References
-
- Altshuler AL, Hillard PJ. Menstrual suppression for adolescents. Curr Opin Obstet Gynecol 2014;26:323–31. doi: 10.1097/GCO.0000000000000098 - DOI
-
- Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003;101:653–61. doi: 10.1016/s0029-7844(03)00014-0 - DOI
-
- Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment. ACOG Committee Opinion No. 817. American College of Obstetricians and Gynecologists. Obstet Gynecol 2021;137:e7–15. doi: 10.1097/AOG.0000000000004209 - DOI
-
- Management of endometriosis. Practice Bulletin No. 114. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223–36. doi: 10.1097/AOG.0b013e3181e8b073 - DOI
-
- Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:197–206. doi: 10.1097/AOG.0b013e318262e320 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources